Orchestra BioMed (OBIO) Tops Q3 EPS by 4c
Tweet
Share
E-mailGet Alerts OBIO Hot Sheet
Join SI Premium – FREE
Orchestra BioMed (NASDAQ: OBIO) reported Q3 EPS of ($0.38), $0.04 better than the analyst estimate of ($0.42). Revenue for the quarter came in at $420 thousand.
For earnings history and earnings-related data on Orchestra BioMed (OBIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies sees a buying opportunity in this S&P 500 sector
- Ackman adds Netflix, Visa and Mastercard in portfolio revamp
- Wolfe Research upgrades Biogen, AbbVie on pipeline strength and valuation
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
